From: Determinants of Food Choice in Athletes: A Systematic Scoping Review
STROBE criteria | Birkenhead [36]a | Tesema et al. [27] | Pelly et al. [25] | Thurecht et al. [30] | Pelly et al. [29] | Blennerr-hassett et al. [28] | Thurecht et al. [32] | Stickler et al. [31] | |
---|---|---|---|---|---|---|---|---|---|
Title and abstract | |||||||||
1 | Design in title | Â | Â | * | * | * | * | * | * |
2 | Informative abstract | * | * | * | * | * | * | * | * |
Introduction | |||||||||
3 | Rationale | * | Â | * | * | * | * | * | * |
4 | Specific objectives | * | * | * | * | * | * | * | * |
Methods | |||||||||
5 | Study design | * | Â | * | * | * | * | * | * |
6 | Setting | * | * | * | * | * | * | * | * |
7 | Participants | * | Â | * | * | * | * | * | * |
8 | Variables | * | Â | * | * | * | * | * | * |
9 | Data source | * | Â | * | * | * | * | * | * |
10 | Bias | Â | Â | Â | Â | Â | Â | Â | Â |
11 | Study size | Â | Â | * | * | Â | Â | * | * |
12 | Quantitative variables | * | Â | * | * | * | * | * | * |
13 | Statistical methods | * | * | * | * | * | * | * | * |
14 | Subgroups & interactions | * | * | * | * | * | * | * | Â |
15 | Missing data | Â | Â | Â | Â | Â | Â | Â | Â |
16 | Sampling strategy | NA | N/A | NA | N/A | N/A | N/A | NA | N/A |
17 | Sensitivity analysis | Â | Â | Â | Â | Â | Â | Â | Â |
Results | |||||||||
18 | Participants | * | Â | * | * | * | * | * | * |
19 | Non-participation | Â | Â | Â | Â | Â | Â | Â | Â |
20 | Flow diagram | Â | Â | Â | Â | Â | Â | Â | Â |
21 | Descriptive data | * | Â | * | * | * | * | * | * |
22 | Missing data | * | Â | Â | N/A | N/A | * | Â | * |
23 | Outcome events | * | Â | * | * | * | * | * | * |
24 | Confounders | Â | Â | Â | Â | Â | Â | Â | Â |
25 | Category boundaries | N/A | N/A | NA | N/A | N/A | N/A | NA | * |
26 | Risk | N/A | N/A | NA | N/A | N/A | N/A | NA | N/A |
27 | Other analyses | * | * | * | * | * | * | * | N/A |
Discussion | |||||||||
28 | Key results | * | * | * | * | * | * | * | * |
29 | Limitations | * | Â | * | * | * | * | * | * |
30 | Interpretation | * | * | * | * | * | * | * | * |
31 | Generalisability | * | Â | Â | * | * | * | * | * |
Other information | |||||||||
32 | Funding | Â | Â | * | * | * | * | * | * |
 | Total score | 20 | 8 | 20 | 22 | 21 | 22 | 22 | 22 |